William Blair Reaffirms “Market Perform” Rating for FibroGen (NASDAQ:FGEN)
William Blair reissued their market perform rating on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research report report published on Tuesday morning,RTT News reports. Several other brokerages have also recently issued reports on FGEN. StockNews.com assumed coverage on FibroGen in a research report on Sunday. They issued a “hold” rating on the stock. […]
William Blair reissued their market perform rating on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research report report published on Tuesday morning,RTT News reports. Several other brokerages have also recently issued reports on FGEN. StockNews.com assumed coverage on FibroGen in a research report on Sunday. They issued a “hold” rating on the stock. […]
